Delivery Order SPE2DB24D9131-SPE2DB25FXRT8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,547.40 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml syringes. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, is structured as a firm fixed-price delivery order without any set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will fulfill this order for delivery to...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $9,284.40 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of September 15, 2025. This delivery order was issued without a set-aside designation and represents a single-line procurement under DLA's existing...
- The Defense Logistics Agency awarded a delivery order valued at $12,379.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, was awarded without set-aside designation. DMS Pharmaceutical Group is registered in the System for Award Management and has maintained...
- The Defense Logistics Agency awarded a delivery order valued at $9,284.40 to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of Xolair 150 mg/1.2 ml powder vials. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, carries no set-aside designation and will be performed in Park Ridge, Illinois, where the vendor is based. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected to fulfill this...
- The Defense Logistics Agency awarded a delivery order valued at $9,284.40 to DMS Pharmaceutical Group Inc. on September 19, 2025, for the supply of XOLAIR 150 mg/ml syringes. This delivery order represents a firm fixed-price contract with an ultimate completion date of October 10, 2025, and carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge....
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, valued at $1,547.40 with an ultimate completion date of September 10, 2025, was issued without set-aside designation. DMS Pharmaceutical Group competes effectively in federal procurement leveraging its small business status and established...
- The Defense Logistics Agency awarded a $11,162.88 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 13, 2025, for the supply of Xolair 300 mg/2 ml syringes. This delivery order carries an ultimate completion date of September 4, 2025, and does not utilize a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge facility. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,321.10 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml syringes, with an ultimate completion date of September 17, 2025. This firm fixed-price delivery order was issued without a set-aside designation on August 26, 2025, and will be performed at the contractor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected to fulfill...
- The Defense Logistics Agency awarded a delivery order valued at $3,720.96 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 ml syringes on September 25, 2025. This firm fixed-price delivery order is scheduled for completion by October 17, 2025, with fulfillment from the contractor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis leveraging its woman-owned small business status....
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 75 mg/0.5 ml syringes. The delivery order, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, carries no set-aside designation. DMS Pharmaceutical Group is executing this order under its larger Indefinite Delivery Contract with...
- SPE2DB24D9131Indefinite Delivery Contract
- SPE2DB24D9131-SPE2DB25FXRT8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,189.60 to DMS Pharmaceutical Group Inc. on September 2, 2025, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, will be performed at the vendor's location in Park Ridge, Illinois. No set-aside designation was used in this award. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, serves as the prime contractor and will provide this specialty pharmaceutical product directly to support federal healthcare needs. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The underlying indefinite delivery vehicle, administered through the SPE2DB program, establishes the framework for the agency to procure a comprehensive range of pharmaceutical products supporting medical supply requirements across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a key supplier in the federal pharmaceutical supply chain, consistently securing contracts for branded and generic prescription drugs, biologics, and specialized medications to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/2/25 |